Navigation Links
Arius announces leading independent proxy firm, RiskMetrics ISS Canada, recommends shareholders vote for the arrangement involving its acquisition by Roche
Date:9/9/2008

ct ARIUS' proxy solicitation agent, The Laurel Hill Advisory Group, toll-free at 1-888-270-2614.

About ARIUS

ARIUS is a biotechnology company discovering and developing the next wave of antibody therapeutics. Established in 1999, ARIUS has built a proprietary technology platform, FunctionFIRST(TM), that rapidly identifies and selects antibodies based on their functional ability to affect disease. This antibody generation engine has enabled ARIUS to assemble a portfolio of more than 500 antibody candidates. In addition to the antibodies it is developing in-house, ARIUS has ongoing partnerships with key biotechnology and drug development companies. ARIUS is listed on the TSX under the symbol "ARI". For further information, visit http://www.ariusmabs.com

Forward-Looking Statements

Certain statements in this news release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, which involve known and unknown risks, uncertainties and other factors that may cause our actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. Forward-looking statements in this release include, but are not limited to, ARIUS successfully advancing its new product programs as well as licensing opportunities. These statements are only predictions and actual events or results may differ materially. Factors that could cause such actual events or results expressed or implied by such forward-looking statements to differ materially from any future results expressed or implied by such statements include, but are not limited to: early stage of development; technology and product development; dependence on and management of current and future corporate collaborations; future capital needs; uncertainty of additional funding; no assurance of market acceptance; dependence on proprietary tech
'/>"/>

SOURCE ARIUS Research Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Darius Naigamwalla Appointed Senior Vice President and Head of the Brand Management Practice at Campbell Alliance
2. Roche starts acquisition process of ARIUS to gain access to new screening platform for antibody therapeutics
3. ARIUS announces second quarter fiscal 2008 financial results
4. ARIUS presents new findings for anti-cancer antibody programs at AACR
5. ARIUS announces first quarter fiscal 2008 financial results
6. ARIUS 2008 Annual and Special Meeting of Shareholders
7. ARIUS recognized for entrepreneurial excellence
8. ARIUS announces five abstracts selected for presentation at 2008 AACR Annual Meeting
9. ARIUS presents new findings showing therapeutic antibody inhibits human leukemic cancer stem cells
10. Laureate Announces Manufacturing Agreement with ARIUS for Trop-2 Targeting Antibody
11. ARIUS announces manufacturing Agreement with Laureate Pharma For Trop-2 targeting antibody
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... , Dec. 22, 2014  Alternative Energy & ... it has signed a letter of intent to ... developed and patented a nanotechnology-based development platform used ... that enable rapid on-site collection and testing to ... health issues in an immediate, non-invasive and cost-effective ...
(Date:12/22/2014)... The American Journal of Hematology/Oncology, ... reviews and editorials addressing developments and pathways related ... a provocative article exploring the role of follicle-stimulating ... treatment of prostate cancer. , The article ... possibility that there could be a connection to ...
(Date:12/19/2014)... Hershey, PA (PRWEB) December 19, 2014 ... a leading developer and manufacturer of needle-free injection ... an agreement with Immunomic Therapeutics, Inc. (“ITI”) for ... injection device with its LAMP™ vaccine platform. ... for an exclusive Worldwide license to the Biojector®-2000 ...
(Date:12/19/2014)... Dec. 19, 2014 Naurex Inc., a biopharmaceutical ... for diseases of the central nervous system, today announced ... executive officer, will present at the 33 rd ... take place at 3:00 p.m. PST on Tuesday, January ... San Francisco, Calif. ...
Breaking Biology Technology:ALNE Announces Intention To Acquire BioTechPharma 2Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 2Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 3Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 4Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines 2Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines 3Naurex to Present at 33rd Annual J.P. Morgan Healthcare Conference 2
... Life Technologies Corporation (NASDAQ: LIFE ) ... Stock Conference on Tuesday, May 10 at 9:45am CT. ... will present on behalf of the company. The company ... three weeks following the conference on the Life Technologies, ...
... Here, Inc., and Richards Partners have been selected ... a wholly owned subsidiary of International Stem Cell ... on therapeutic and research products.  Lifeline offers luxury ... stem cell technology.  Based in Dallas and part ...
... promise of superfast computers and ultrapowerful optical microscopes ... of the hottest fields in high-technology. However, to ... that feature interfaces between noble metals and dielectrics. ... (DOE),s Lawrence Berkeley National Laboratory (Berkeley Lab) have ...
Cached Biology Technology:Life Technologies to Present at Baird's 2011 Growth Stock Conference 2Lifeline Skin Care™ Selects Click Here, Inc., Richards Partners 2Lifeline Skin Care™ Selects Click Here, Inc., Richards Partners 3New kid on the plasmonic block 2New kid on the plasmonic block 3New kid on the plasmonic block 4New kid on the plasmonic block 5
(Date:12/22/2014)... 2014  The 2014 Holiday Season may be ... Acuity Market Intelligence reports that the long anticipated ... Acuity forecasts that intensifying demand for smart phones, ... will drive a global market of 2.5 billion ... 2020.   According to Maxine ...
(Date:12/17/2014)... DUBLIN , Dec. 15, 2014 Research ... announced the addition of the "Samsung Galaxy ... Analysis" report to their offering. ... on a totally different sensing technology than the ... a fingerprint sensor in its product. ...
(Date:12/17/2014)...  Automation is fundamentally transforming the travel experience ... international borders. Over the past decade, ePassports, biometric ... travelers to self process through border control via ... an increasing number of airports, seaports, and land ... to Maxine Most , Principal at Acuity ...
Breaking Biology News(10 mins):First Season of Holiday Shopping with Mobile Biometric Payments Wraps Up With a Present for Biometrics Industry: A Rosy Forecast for More Than 2 Billion Users of 4.8 Billion Mobile Biometric Devices by 2020 2Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2
... kill bacteria could be making them stronger, according to ... journal Microbiology . Low levels of these chemicals, ... aureus remove toxic chemicals from the cell even more ... some antibiotics. Biocides are used in disinfectants and ...
... Top 100 Internet Retailers, BOISE, Idaho, Oct. ... provider of fraud control for ecommerce merchants, has ... National Account Sales,directors. Together, they bring Kount customers ... ecommerce fraud control and online,payments., Scott Lewer ...
... New Haven, Conn. Yale researchers have harnessed the power ... in 1916 that plants with rapid reproductive cycles evolve ... Science . "Our study has profound consequence for ... of the computer in revealing major evolutionary patterns," said senior ...
Cached Biology News:Disinfectants can make bacteria resistant to treatment 2Kount Lands Veteran Fraud Experts From Retail Decisions and iovation 2Reproducing early and often is the key to rapid evolution in plants 2
Umbilical cord blood CD14+ Monocytes, For immunohistochemistry (IHC) Cell Chip with Human Umbilical Cord Blood Monocytes, B Cells and NK Cells...
Umbilical cord blood basophils, For immunohistochemistry (IHC)...
Human peripheral blood neutrophils, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Granulocytes...
Human peripheral blood CD14+ monocytes, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Monocytes, B Cells, NK Cells and Stem Cells...
Biology Products: